Tokyo Tape
Sign in
← Kawaguchi Chemical Industry

Quarterly report · Q1

4361.TEDINET S100QJKH
Period2022-12-01 → 2023-02-28
Filed2023-04-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥2.1bn2022-12-01 → 2023-02-28Cons.Net sales
Revenue¥8.4bn2021-12-01 → 2022-11-30Cons.Net sales (5-year summary)
Revenue¥1.9bn2021-12-01 → 2022-02-28Cons.Net sales
Operating income¥47m2022-12-01 → 2023-02-28Cons.Operating income
Operating income¥114m2021-12-01 → 2022-02-28Cons.Operating income
Ordinary income¥46m2022-12-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥303m2021-12-01 → 2022-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥118m2021-12-01 → 2022-02-28Cons.Ordinary income
Profit before tax¥46m2022-12-01 → 2023-02-28Cons.Income before income taxes
Profit before tax¥118m2021-12-01 → 2022-02-28Cons.Income before income taxes
Net income (owners)¥41m2022-12-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥219m2021-12-01 → 2022-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥95m2021-12-01 → 2022-02-28Cons.Profit loss attributable to owners of parent
Net income¥41m2022-12-01 → 2023-02-28Cons.Profit loss
Net income¥95m2021-12-01 → 2022-02-28Cons.Profit loss
Total assets¥8.2bnat 2023-02-28Cons.Assets
Total assets¥8.3bnat 2022-11-30Cons.Assets
Total assets¥7.8bnat 2022-02-28Cons.Total assets (5-year summary)
Total liabilities¥5.8bnat 2023-02-28Cons.Liabilities
Total liabilities¥5.9bnat 2022-11-30Cons.Liabilities
Net assets / equity¥2.4bnat 2023-02-28Cons.Net assets
Net assets / equity¥2.4bnat 2022-11-30Cons.Net assets
Net assets / equity¥2.3bnat 2022-02-28Cons.Net assets (5-year summary)
Cash and deposits¥864mat 2023-02-28Cons.Cash and deposits
Cash and deposits¥911mat 2022-11-30Cons.Cash and deposits
EPS (basic)¥33.772022-12-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥179.752021-12-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥78.242021-12-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
Equity ratio29.1%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio29.0%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio29.4%at 2022-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segmentrevenue2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2022-12-01 → 2023-02-28¥39m
jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segmentrevenue2022-12-01 → 2023-02-28¥10m
jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segmentrevenue external2022-12-01 → 2023-02-28¥10m
jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segmentsegment profit2022-12-01 → 2023-02-28¥8m
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-02-28¥2.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-02-28¥2.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-02-28¥47m
jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segmentrevenue2021-12-01 → 2022-02-28¥1.9bn
jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2021-12-01 → 2022-02-28¥1.9bn
jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2021-12-01 → 2022-02-28¥106m
jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segmentrevenue2021-12-01 → 2022-02-28¥9m
jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segmentrevenue external2021-12-01 → 2022-02-28¥9m
jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segmentsegment profit2021-12-01 → 2022-02-28¥8m
Total Of Reportable Segments And Otherssegment totalrevenue2021-12-01 → 2022-02-28¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-12-01 → 2022-02-28¥1.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-12-01 → 2022-02-28¥114m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 337
ItemContextValueUnit
Accrued consumption taxesPrior1YearInstant－JPY
Accrued consumption taxesCurrentQuarterInstant32690000JPY
Provision for bonusesPrior1YearInstant－JPY
Provision for bonusesCurrentQuarterInstant41733000JPY
Provision for directors bonusesPrior1YearInstant16500000JPY
Provision for directors bonusesCurrentQuarterInstant3375000JPY
Other clPrior1YearInstant339654000JPY
Other clCurrentQuarterInstant68196000JPY
Current liabilitiesPrior1YearInstant4422416000JPY
Current liabilitiesCurrentQuarterInstant4370349000JPY
Long term loans payablePrior1YearInstant965318000JPY
Long term loans payableCurrentQuarterInstant949484000JPY
Provision for directors retirement benefitsPrior1YearInstant102690000JPY
Provision for directors retirement benefitsCurrentQuarterInstant73890000JPY
Net defined benefit liabilityPrior1YearInstant290979000JPY
Net defined benefit liabilityCurrentQuarterInstant301782000JPY
Other nclPrior1YearInstant128773000JPY
Other nclCurrentQuarterInstant143509000JPY
Noncurrent liabilitiesPrior1YearInstant1487760000JPY
Noncurrent liabilitiesCurrentQuarterInstant1468665000JPY
LiabilitiesPrior1YearInstant5910177000JPY
LiabilitiesCurrentQuarterInstant5839014000JPY
Capital stockPrior1YearInstant610000000JPY
Capital stockCurrentQuarterInstant610000000JPY
Capital surplusPrior1YearInstant58437000JPY
Capital surplusCurrentQuarterInstant58437000JPY
Retained earningsPrior1YearInstant1686444000JPY
Retained earningsCurrentQuarterInstant1666689000JPY
Treasury stockPrior1YearInstant-8202000JPY
Treasury stockCurrentQuarterInstant-8202000JPY
Shareholders equityPrior1YearInstant2346679000JPY
Shareholders equityCurrentQuarterInstant2326924000JPY
Valuation difference on available for sale securitiesPrior1YearInstant27233000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant31309000JPY
Foreign currency translation adjustmentPrior1YearInstant37433000JPY
Foreign currency translation adjustmentCurrentQuarterInstant38919000JPY
Valuation and translation adjustmentsPrior1YearInstant64667000JPY
Valuation and translation adjustmentsCurrentQuarterInstant70229000JPY
Net assetsPrior1YearInstant2411347000JPY
Net assetsCurrentQuarterInstant2397153000JPY
Liabilities and net assetsPrior1YearInstant8321524000JPY
Liabilities and net assetsCurrentQuarterInstant8236168000JPY
Net salesPrior1YTDDuration1943437000JPY
Net salesCurrentYTDDuration2051990000JPY
Cost of salesPrior1YTDDuration1542052000JPY
Cost of salesCurrentYTDDuration1719648000JPY
Gross profitPrior1YTDDuration401385000JPY
Gross profitCurrentYTDDuration332342000JPY
Selling general and administrative expensesPrior1YTDDuration287380000JPY
Selling general and administrative expensesCurrentYTDDuration285837000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-11-30pass
balance sheet identityconsolidated 2023-02-28pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2021-12-01/2022-02-28pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-02-28pass
statement vs summary · revenueconsolidated 2021-12-01/2022-02-28pass
statement vs summary · revenueconsolidated 2022-12-01/2023-02-28pass
statement vs summary · total assetsconsolidated 2022-11-30pass
statement vs summary · total assetsconsolidated 2023-02-28pass